Pharmaceuticals, Biotechnology and Life Sciences
Recommendation for approval based on results from pivotal Phase 3 MEDALIST and BELIEVE studies PRINCETON, N.J. & CAMBRIDGE, Mass.–(BUSINESS WIRE)–$BMY…
LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, and Bixink Therapeutics, a new South Korean company working in…
Conference Call Scheduled for Thursday, May 7, 2020 at 4:30 p.m. ET NEWARK, Calif.–(BUSINESS WIRE)–Revance Therapeutics, Inc. (Nasdaq: RVNC), a…
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on developing immune modulators and…
— McDowell joins with over two decades of biopharma legal and strategic experience at development and commercial stage companies SOUTH…
-ADCETRIS® (Brentuximab Vedotin) Net Sales in U.S. and Canada of $164.1 Million in the First Quarter, an Increase of 22…
– Product Sales of $5.5 billion – – Diluted EPS of $1.22 per share – – Non-GAAP Diluted EPS of…
New subcutaneous formulation reduces the time taken for patients to receive daratumumab treatment from hours to approximately three to five…
Premier data from New York members shows strong surges in demand for cardiovascular and blood thinning drugs. Premier recommends urgent…
Cambridge, MA-based clinical research organization to be responsible for Clinical Trial Site Management and On-Site Monitoring in the United States…